 Mark Kohler
Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 8 | 2025 | 342 | 2.780 |
Why?
| | T-Lymphocytes | 9 | 2025 | 1997 | 1.780 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2024 | 923 | 0.920 |
Why?
| | Antigens, CD19 | 2 | 2025 | 128 | 0.900 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2025 | 297 | 0.800 |
Why?
| | Neuroblastoma | 3 | 2010 | 174 | 0.630 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2023 | 1146 | 0.580 |
Why?
| | Erythropoietin | 1 | 2020 | 100 | 0.580 |
Why?
| | Genetic Engineering | 1 | 2019 | 88 | 0.570 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2019 | 673 | 0.550 |
Why?
| | Membrane Proteins | 1 | 2025 | 1166 | 0.550 |
Why?
| | Antigens, Neoplasm | 3 | 2019 | 271 | 0.470 |
Why?
| | Cancer Vaccines | 4 | 2018 | 162 | 0.450 |
Why?
| | Sialic Acid Binding Ig-like Lectin 2 | 2 | 2025 | 21 | 0.450 |
Why?
| | Cell Line, Tumor | 6 | 2025 | 3551 | 0.360 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2025 | 936 | 0.360 |
Why?
| | Lymphocyte Activation | 5 | 2025 | 1133 | 0.340 |
Why?
| | CD28 Antigens | 2 | 2025 | 59 | 0.260 |
Why?
| | Gene Expression Profiling | 2 | 2010 | 1777 | 0.250 |
Why?
| | Stem Cells | 1 | 2010 | 630 | 0.230 |
Why?
| | Mice | 8 | 2025 | 18357 | 0.220 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1450 | 0.210 |
Why?
| | Animals | 11 | 2025 | 38100 | 0.200 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2025 | 426 | 0.180 |
Why?
| | Perforin | 1 | 2020 | 22 | 0.160 |
Why?
| | Phosphorylation | 1 | 2025 | 1708 | 0.160 |
Why?
| | Clinical Trials as Topic | 1 | 2025 | 1062 | 0.160 |
Why?
| | Receptors, Antigen | 2 | 2017 | 15 | 0.150 |
Why?
| | Tumor Escape | 1 | 2019 | 49 | 0.140 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2025 | 688 | 0.140 |
Why?
| | Immunomodulation | 1 | 2019 | 99 | 0.140 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2018 | 41 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 979 | 0.140 |
Why?
| | Cell Proliferation | 1 | 2025 | 2514 | 0.130 |
Why?
| | Mitochondria | 1 | 2024 | 992 | 0.130 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2015 | 23 | 0.110 |
Why?
| | 4-1BB Ligand | 1 | 2014 | 7 | 0.110 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2014 | 35 | 0.110 |
Why?
| | Interleukin-15 | 1 | 2014 | 95 | 0.100 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2014 | 73 | 0.100 |
Why?
| | Erythrocytes | 1 | 2020 | 749 | 0.100 |
Why?
| | B7-2 Antigen | 2 | 2010 | 27 | 0.100 |
Why?
| | B7-1 Antigen | 2 | 2010 | 55 | 0.100 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2007 | 411 | 0.100 |
Why?
| | Hematologic Neoplasms | 1 | 2015 | 168 | 0.090 |
Why?
| | Humans | 11 | 2025 | 145750 | 0.090 |
Why?
| | Graft vs Host Disease | 1 | 2014 | 279 | 0.090 |
Why?
| | Vaccination | 2 | 2010 | 1428 | 0.090 |
Why?
| | Flow Cytometry | 2 | 2017 | 1165 | 0.080 |
Why?
| | Signal Transduction | 1 | 2025 | 5223 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2014 | 481 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 751 | 0.080 |
Why?
| | NIMA-Related Kinases | 1 | 2010 | 9 | 0.080 |
Why?
| | Blotting, Western | 2 | 2010 | 1184 | 0.080 |
Why?
| | Luciferases | 1 | 2010 | 154 | 0.080 |
Why?
| | RNA, Neoplasm | 1 | 2010 | 83 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2010 | 396 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2024 | 5992 | 0.070 |
Why?
| | Cluster Analysis | 1 | 2010 | 501 | 0.070 |
Why?
| | Neoplasms | 2 | 2019 | 2913 | 0.070 |
Why?
| | Skin Neoplasms | 1 | 2014 | 852 | 0.060 |
Why?
| | Survival Analysis | 1 | 2010 | 1378 | 0.060 |
Why?
| | Oncogene Proteins | 1 | 2007 | 62 | 0.060 |
Why?
| | Adoptive Transfer | 2 | 2018 | 200 | 0.060 |
Why?
| | Female | 5 | 2025 | 79025 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 105 | 0.050 |
Why?
| | Ovalbumin | 1 | 2024 | 194 | 0.050 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 109 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 478 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2010 | 1329 | 0.050 |
Why?
| | Immune Tolerance | 1 | 2006 | 385 | 0.050 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2003 | 93 | 0.050 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2003 | 92 | 0.050 |
Why?
| | Blood-Brain Barrier | 1 | 2003 | 160 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 263 | 0.040 |
Why?
| | Macrophage Activation Syndrome | 1 | 2020 | 22 | 0.040 |
Why?
| | Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 29 | 0.040 |
Why?
| | Models, Immunological | 1 | 2020 | 99 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 1482 | 0.040 |
Why?
| | Research Design | 1 | 2025 | 1139 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2020 | 1049 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4569 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2020 | 507 | 0.030 |
Why?
| | Graft vs Leukemia Effect | 1 | 2014 | 12 | 0.030 |
Why?
| | Unrelated Donors | 1 | 2014 | 39 | 0.030 |
Why?
| | Transplantation Chimera | 1 | 2014 | 57 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 2014 | 123 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 2014 | 132 | 0.030 |
Why?
| | Siblings | 1 | 2014 | 196 | 0.030 |
Why?
| | Interleukin-2 | 1 | 2015 | 440 | 0.030 |
Why?
| | Treatment Failure | 1 | 2014 | 360 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2014 | 419 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2020 | 3130 | 0.020 |
Why?
| | Cytokines | 1 | 2020 | 2069 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2823 | 0.020 |
Why?
| | Acute Disease | 1 | 2014 | 1036 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2865 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 2443 | 0.020 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2007 | 33 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4151 | 0.020 |
Why?
| | Gene Library | 1 | 2007 | 122 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2007 | 273 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2007 | 365 | 0.010 |
Why?
| | Receptors, Interleukin-2 | 1 | 2006 | 64 | 0.010 |
Why?
| | CD4 Antigens | 1 | 2006 | 137 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 2007 | 274 | 0.010 |
Why?
| | Immunization | 1 | 2007 | 375 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 849 | 0.010 |
Why?
| | Macaca mulatta | 1 | 2003 | 186 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2007 | 1505 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2003 | 1723 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 22569 | 0.010 |
Why?
| | Adult | 1 | 2014 | 40867 | 0.010 |
Why?
| | Brain | 1 | 2003 | 2969 | 0.010 |
Why?
| | Male | 1 | 2014 | 72992 | 0.000 |
Why?
|
|
Kohler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|